무바늘 약물전달 디바이스 시장 규모, 점유율 및 성장 분석 : 유형별, 용도별, 지역별 - 업계 예측(2026-2033년)

Needle-free Drug Delivery Devices Market size was valued at USD 15.07 Billion in 2024 and is poised to grow from USD 16.11 Billion in 2025 to USD 27.48 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global market for needle-free drug delivery devices is poised to revolutionize the healthcare sector with its innovative solutions. By eliminating traditional needles, these devices mitigate the risks associated with needle use and significantly reduce patient discomfort. Rising demand for pain-free and patient-centric drug administration, particularly in managing chronic conditions like autoimmune disorders and diabetes, is driving market growth. Furthermore, the aging population and the need for self-injected drugs are contributing factors. Innovations, such as transdermal patches and jet injectors, enhance convenience and precision, boosting their popularity. While healthcare facilities remain the primary market segment prioritizing patient comfort, homecare settings are rapidly gaining ground. However, high development costs and regulatory challenges may pose barriers to market expansion, despite its promising trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Needle-free Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Needle-free Drug Delivery Devices Market Segments Analysis

Global Needle-free Drug Delivery Devices Market is segmented by Type, Application and region. Based on Type, the market is segmented into Inhaler technology, Transdermal patch technology and Novel needle-free technologies. Based on Application, the market is segmented into Vaccine delivery, Pain management, Insulin delivery for diabetes, Pediatric injections and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Needle-free Drug Delivery Devices Market

The Needle-free Drug Delivery Devices market is experiencing significant growth, driven by the advent of innovative devices characterized by enhanced precision and efficiency. This evolution is largely attributed to ongoing advancements in needle-free drug delivery technologies. The emergence of sophisticated solutions such as transdermal patches, micro-needles, and jet injectors exemplifies this progress, allowing for versatile applications across various medical scenarios. As technology continues to advance, these devices are becoming increasingly precise, catering to a broader range of therapeutic needs and improving the overall patient experience by reducing the discomfort associated with traditional needle-based methods.

Restraints in the Needle-free Drug Delivery Devices Market

The needle-free drug delivery devices market faces significant challenges due to stringent regulatory requirements that govern the medical device industry. The process of obtaining approval for these innovative products is often lengthy and complex, creating hurdles for manufacturers. While these regulations are essential for ensuring patient safety and the efficacy of drug delivery, they can also lead to increased development costs and protracted timelines for production and distribution. As companies navigate the intricacies of compliance, the potential for delays in bringing products to market poses a considerable restraint on industry growth and innovation.

Market Trends of the Needle-free Drug Delivery Devices Market

The Needle-free Drug Delivery Devices market is experiencing significant expansion beyond traditional applications like insulin and vaccines, as advancements in technology broaden their use in specialized therapeutics and biologics. This market trend reflects a growing demand for innovative solutions that ensure controlled and accurate drug administration. The versatility of needle-free devices is being increasingly recognized, enabling their adoption in various therapeutic areas, including chronic disease management and pediatric care, where minimizing pain and enhancing patient compliance are crucial. As industry stakeholders continue to innovate and explore new applications, the market is poised for substantial growth, driven by evolving healthcare needs and preferences.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis
• Patent Analysis

Global Needle-free Drug Delivery Devices Market Size by Type & CAGR (2026-2033)

• Market Overview
• Inhaler technology
• Transdermal patch technology
• Novel needle-free technologies

Global Needle-free Drug Delivery Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Vaccine delivery
• Pain management
• Insulin delivery for diabetes
• Pediatric injections
• Others

Global Needle-free Drug Delivery Devices Market Size & CAGR (2026-2033)

• North America (Type, Application)
  • US
  • Canada
• Europe (Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• PenJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zealand Pharma (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCB S.A. (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verdict Media Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INJEX Pharma AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antares Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crossject SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MannKind Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mika Medical Co. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Halozyme, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akra Dermojet (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring B.V. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MIIST Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations